The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
about
Proteomics and phosphoproteomics in precision medicine: applications and challenges.Association between MTHFR microRNA binding site polymorphisms and methotrexate concentrations in Chinese pediatric patients with acute lymphoblastic leukemia.Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia
P2860
The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@ast
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@en
type
label
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@ast
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@en
prefLabel
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@ast
The Promise of Pharmacogenomic ...... eukemia Maintenance Treatment.
@en
P2860
P921
P1476
The Promise of Pharmacogenomic ...... Leukemia Maintenance Treatment
@en
P2093
Marcus Marable
Shoshana Rudin
P2860
P356
10.1016/J.GPB.2016.11.003
P5008
P577
2017-04-01T00:00:00Z
2017-04-06T00:00:00Z